Bucs Stun Division Rival Panthers and ESPN

Buccaneers Beat Panthers in Win and Climb in ESPN Rankings


Football teams move up and down every week in terms of how well they played in their last game. There are often power rankings on sports site that mention this.


The Tampa Bay Buccaneers are just one recent example of how these power rankings play out over the course of a typical NFL season. The Bucs manage to pull off a stunning upset of the division rival Carolina Panthers during a Monday Night Football game, winning by a score of 17-14 and tightening the NFC South division race, now with a 2-3 record.


Notably absent from the game was Panthers quarterback Cam Newton, who had previously suffered a concussion and was now on the league’s concussion protocol, forcing him to sit out the game. Derek Anderson, the backup was now thrust into the starter position and it was noticeable, due to the fact that the Panthers now sit at 1-4 for the season and last place in the division.


ESPN definitely took notice of this, moving the Bucs up six spots due to the win, from 29th place last week up to 23 after this win. A necessary move for them to jump several shots, given that the Bucs had already lost three straight games prior to Monday Night and were sitting in the basement of rankings across all sports boards, ESPN included. The Bucs’ defense did give up lots of offensive yards and big plays but ultimately made a game-changing play to keep them alive, that play being a well-time red zone interception of Derek Anderson. Roberto Aguayo, the rookie placekicker, made the game-winning field goal to give the Bucs their second win.


The Buccaneers are around other teams like the Indianapolis Colts and Detroit Lions in terms of rankings because like the Bucs, they also came up with wins when they needed them, however theirs were more impressive. At the same time, power rankings on any site, be it ESPN or the NFL, don’t determine the final record for the season or how well everything plays out but does right now. The goal of any team should be to try for that number one spot in all power rankings.

Succeeding in real estate; the case of Boraie Development

Boraie Development LLC deals with sales & marketing, real estate development, and property management. The company was founded by Omar Boraie thirty years ago. It has its headquarters in New Brunswick. The Boraie Company has also expanded to Newark and Atlanta City. Omar Boraie was from Egypt and had gone to New Brunswick to get his Ph.D. in chemistry. It is then that he ventured into real estate. Over the years, his company has become a leader in the industry.

Omar Boraie is the president of the company and a successful entrepreneur. He is expected to improve the real estate sector in Newark and Atlanta city like the one he did in New Brunswick. The development of very urban projects in a place like New Brunswick was not easy. Many people thought that his project would fail. The first tower by Boraie Development in New Brunswick was a success. After its completion in 2007, it sold out in around 2months. Omar Boraie’s son, Wasseem Boraie is the vice president of the company.

For around 30 years, the company has been involved in real estate development. The team has the required expertise and experience in the field. Having good partners who believe in you in this business is important as it will reflect on the quality of projects. Omar Boraie mostly partners with banks that give them funds to start on projects. The long time that the company has been dealing with real estate development in New Brunswick helps in understanding the market. This being the case, the company is able to come up with timely projects, which will attract clients soon after completion.

In the property management department, the company mostly deals with leasing, maintenance of the property, accounting, and administration. The property management team at Boraie ensures that all the properties on boraierealty.com under them are in good condition. Since this team is also in charge of leasing, it deals a lot with clients. Good customer service benefits the business by making the tenants stay longer and give good reviews. This is a sure way of getting, even more, clients.

Omar Boraie has also specialized in sales and marketing of the property. This is mostly dependent on the other services. The success of the other departments makes it easier for the sales and marketing team. This department also provides meaningful information on the latest market trends. This way, the company continues to come up with properties, which suit the needs of the people.

An In-Depth Look Into The Life Of George Soros And His Sudden Re-Emergence

Born in 1930, George Soros is a successful entrepreneur and his journey in business has earned him a position among the most respected billionaires in America and the world at large. He has founded several companies and affiliations like F.M Mayer, Arnhold & S. Bleichroeder, Wertheim & Company and Soros Fund Management.

Soros is also an active supporter of political activities and his first overwhelming appearance was in September 1992 when he placed a risky investment of $10 billion on currency speculation. He was right on his prediction and made a whooping $1 billion profit on this day day, according to an Investopedia article.

Sudden re-emergence
People have known George Soros as a strong supporter of what he believes in, something that has driven his businesses to the peak. Recently, Soros made a comeback with a $25 million splash directed at 2016 Hillary Clinton’s presidential campaigns. He had made such a donation back in 2004 during his campaign to unseat President George Bush, but later changed his mind.

According to Politico, he is expected to give more as the elections draw nearer. His advisor Michael Vachon in an interview with Politico alleged that Soros is a consistent donor and his support for the Democratic will remain stronger now that Hillary, whom he has had a good relationship with for many years, is contesting for the presidential seat through the party.

The most recent Forbes estimate placed his net worth at $24.9 billion and his comeback is seen as a major contribution on en.wikipedia.org that will push the party to retain the control of the White House and emerge with the majority in the Senate.

Apart from business, George Soros has also authored several books touching on business and socio-economic issues facing the world. He published his first book The Alchemy Of Financein 1988. His interest in politics has come as a challenge to the opponents of Hillary as he has pledged to even inject more support to her campaign and journey to the White House.

Investment style
George Soros is a renowned expert in translating broad-brush trends in the business world. He has worked as a short-term speculator and his bets have always been huge and accurate most of the time. His belief on the fact that financial markets can be chaotic has allowed him to leverage strategies that have earned huge profits.

As of 2000 when he retired, he had won major bets in the financial markets, earning him and his associates billions in profits. Although he made few mistakes during his journey in business, he remains one of the wealthiest investors in the world. Soros’ successful Quantum Fund continues to bring in profits many years after establishment.

Deciphering the Operations and Functions of Investment Banking

Investment banking entails a category of financial services provided by investment banks. This type of banking services mainly focuses on underwriting the issuance of shares and selling of securities in a bid to raise capital for companies. On the other hand, commercial banking specializes in deposits as well as commercial loans.

Buy and Sell Side

Investment banks act as mediators between buyers and companies issuing their securities. This means that investment banking functions under two lines of business including the buy side and the sell side. Sell-side functions entail marketing financial products, publishing financial research and underwriting new lines of stock. Alternatively, the buy-side operations include activities like portfolio management and securities trading.

The regulations governing investment banking are necessary since investment banks operate on both the sell and buy side. The regulations are put in place to prevent the operations on either side from interacting leading to ethics violations or unfair market practices.

Investment Banking Activities

Investment banking activities are split into the front, middle and back office. The front office functions or activities are associated with revenue generation. This category of activities includes markets and investment banking. The middle office constitutes of internal corporate strategy, internal controls and treasury management operations. Lastly, the back office operations involve cross-checking the data for trades conducted to make sure that they are correct as well as transacting the needed transfers.

Martin Lustgarten

Martin Lustgarten is an accomplished investment banker who is mainly based in Florida. His reputation is entangled mainly around his investment banking firm known as Lustgarten, Martin. He is a huge believer of diversifying one’s investment or wealth. As so, Lustgarten has maintained a trend of spreading his wealthy in several nations around the world. This trend has allowed him to limit his risk while expanding his wealth portfolio.

Apart from diversifying his investment portfolio, he has exuded a knack for keeping a close watch on each market, which allows him to react when he spots a market downturn. Martin utilizes his experience and expertise to spot emerging trends.This has proven to be a significant portion of his recipe for success. In respect of his insight in investment banking, he is one of the best go-to investment bankers in the world.

For more information please visit http://mlustgarten.blogspot.com/

Tampa Bay Looks Forward to Coming Weeks

As they entered the 2016 NFL Season, fans of the Tampa Bay Buccaneers were very optimistic about the new season. In 2015 the team was considered one of the most improved in the NFL as they increased their win total from just two to six. Due to the strong play of quarterback Jameis Winston and running back Doug Martin, it appeared that the team could be ready to take the next step forward.


While there was a lot of promise to the upcoming season, the first four weeks of the year did not go as planned as the team lost three of their four games. However, according to recent news (http://thepewterplank.com/2016/10/11/buccaneers-win-changes-seasons-outlook/), the team played very well this week on Monday Night Football and defeated the defending NFC champs, the Carolina Panthers. After winning the game on a last-minute field goal, there is suddenly a lot of optimism about what the team could accomplish the rest of the way.


After winning the game, the Buccaneers are now 2 and 3, which places them in third place in the division and two games behind the Atlanta Falcons. The Buccaneers clearly have the talent to win the division, as they are the only team in the NFL to beat the Falcons, which they did in the first week of the season. During week 6 the team will be on a bye week and they will begin to focus on the rest of the year.


One of the greatest opportunities that the team has coming up is the return of their star running back, Doug Martin. Martin was hurt early in the second game of the year and has yet to retune, but he is expected by many to be back after the bye week. This is an area where Tampa Bay has struggled, as the backup running backs have not been able to completely replace all of the production that Martin left behind during his absence over the past few weeks.


With several divisional games still on the schedule, the Buccaneers have a great chance to gain ground on the Falcons and the rest of the conference. As Winston continues to mature and develop, he will be tough to stop by the end of the year.

The Tampa Bay Rays Finish a Difficult 2016 Season

Not much went right for the Tampa Bay Rays during the 2016 season. The team began spring training with the idea that they would be contenders in the very strong American League East. However, this is not how things would eventually work out for the club. The division was actually much tougher than anyone expected. In fact, the American League East was the only division in the majors to have four teams with a winning record. Needless to say, having to play the Blue Jays, Red Sox, Orioles and Yankees many times made the season very difficult for the Rays to endure.


The Rays eventually finished the season in last place with a record of 68 wins and 94 losses. There were many factors that led to the Rays compiling a record that was worse than every other team in the American League except the Minnesota Twins. One of the biggest disappointments was the performance of starting pitcher Chris Archer. He had been one of the best pitchers in baseball for the past three seasons. There were big expectations for him. He turned 27 in 2016. This is traditionally the age when most baseball players have their biggest season. However, things did not go according to plan for Archer. His earned run average for the season was a very unimpressive 4.02. This was a major increase from the stellar 3.23 earned run average he posted in 2015. He also surrendered 30 home runs in 2016. This was 11 more than he had ever surrendered before in a single season. Archer would finish the season with 19 losses.


The offense was also a big letdown for the team. Rays manager Kevin Cash thought that his lineup was very balanced and would get on base frequently. However, that was not the case. The only thing the Rays did well offensively in 2016 was hit home runs. Unfortunately, their inability to get on base consistently hurt the club. Far too many of their home runs were solo shots. Their inability to score runs on a regular basis put their pitching staff under a great deal of pressure. Rays hitters also struck out far too frequently. Kevin Cash attributes this to a lack of strike zone knowledge and plate discipline.

Remalda files a lawsuit against Laidlaw

Remalda Therapeutics announced recently that they were filing a lawsuit against Laidlaw & Company UK. Remalda develops therapies for people suffering from chronic pain. They are filing their lawsuit against Laidlaw in the U.S. District Court in Nevada. Remalda hopes that the lawsuit will help them regain much of what they lost by working with Laidlaw.

The lawsuit against Laidlaw features several important complaints. Remalda claims that Laidlaw breached their fiduciary duty by disclosing confidential information when they started working as Remalda’s investment banking. Remalda is seeking monetary damages from the fees and costs that were incurred responding to Laidlaw’s materials.

Remalda has had great success working in the courts to get reparations. The Nevada court has already issued a restraining order in another case against Laidlaw. Remalda wants compensation for the damages that Laidlaw has inflicted on them.The company has issued a press release and sent a notice to their stockholders. They are very confident that the lawsuit will end in their favor.

Laidlaw and Company are a full-service investment banking and brokerage firm. The company is lead by principals Matthew Eitner and James Aherm. The company has a 170-year history of serving their customers with integrity, but in recent years the firm has gone down hill. Laidlaw is fending off multiple lawsuits, including the one from Remalda. Additionally, several workers have complained of the harsh working conditions at Laidlaw. The company earns a mere three stars on Glassdoor. They don’t help their interns reach their potential and have been accused of taking advantage of their work ethic. Laidlaw is heading downhill if they do not take action soon.

Remalda is struggling because they trusted Laidlaw and Company. Fortunately, it looks like Laidlaw is making progress within the United States courts. The issue should be rectified soon and Eitner and Aherm will be punished.

Clay Seagall’s plan for Seattle to expand its employee and drug products

Seattle Genetic has plans to expand the use of its first cancer drug. The company plans to widen its shelf of drugs with multiple new drugs set for cancer treatment. The Bothell-based company is also set to increase its number of employees. Advancements made by the company is to enable it achieve its vision.

According to the company Chief Executive Officer, Dr. Clay Siegall, Seattle Genetics has tried its first Adcetris drug in several situations. There have been up to 70 different trials of the drug on multiple cancer cells. Results from the drug show that it is going to be used to fight lymphomas. The company has made a huge revenue from selling the drug. It made $226 million in terms of revenue the previous year. Seattle Genetics has partnered with several pharmaceuticals, this has seen the drug being sold to several parts of the world especially in Canada and the US.

With the new plan to introduce more drugs in the market, Adcetris is going to be another drug produced by the company. Seattle Genetics is currently working to release 12 more drugs. One of the drugs currently has the label 33A. It will be through with clinical trials before the end of 2016. The drug is going to be highly resourceful in the treatment of leukemia. The company has also ventured into other drugs that focus on treatment of bladder cancer and breast cancer. Seattle Genetics today has approximately 800 employees. It has plans to expand by acquiring an additional 100 employees.

Dr. Clay Siegall co-founded Seattle Genetics, he has worked under the company for many years now. He served as the Interim Chairman since April 2004. He has been the director of the company since it was started in 2007. Clay has had a keen interest to help cancer patients. This has seen him work with several national research and treatment institutions that focus on treatment of cancer. He has received multiple awards for his efforts. His success is highly attributed to his educational background. He has a Ph.D. in Genetics and a B.S. in Zoology.

Tampa Bay Continues Team Development with Win

In the 2015 NFL season one of the more surprising teams in the NFL were the Tampa Bay Buccaneers. While the team finished with a record of just 6 wins and 10 losses, it was a big improvement over the 2014 season when they won just four games. Much of the improvement was due to the success of rookie quarterback Jameis Winston, who was the former number one pick in the NFL draft and quickly showed that he belongs in the NFL.


After a good year in 2015, many people expected that the Buccaneers would take another step forward and potentially compete for a spot in the NFL Playoffs. However, the team did not get off to a great start through the first quarter of the season, which saw them start with a record of 1 win and 3 losses. The early season losses included a few blowout losses including those to the Arizona Cardinals and Denver Broncos.


While the Buccaneers looked like they were heading towards another losing season, a recent news article (http://www.nj.com/sports/nfl/2016/10/tampa_bay_buccaneers_vs_caroli.html) pointed out that they did a good job redeeming themselves earlier this week on Monday Night Football.


In front of a national audience, the young Buccaneers team took on the Carolina Panthers, which went to the Super Bowl last year. The Panthers were also off to a poor start this year and were missing their star quarterback, Cam Newton, and starting running back, Jonathan Stewart. Despite the losses of key players, many expected the Panthers to win the game.


The Buccaneers quickly showed during the game that they were not a team to be overlooked. Their defense was very strong and continued to hold the Panthers who had a tough time moving the ball down the field. Winston looked strong and efficient throughout the game as he finished with 219 yards passing and one touchdown without throwing an interception.


In the end, the game came down to special teams play. With the score tied up with no time left on the close, the Buccaneers kicker made a 38-yard field goal to win the game by a score of 17-14. The victory helped Tampa Bay to stay in competition for the NFC South Division, which is currently led by Atlanta.

Seattle Genetics Demonstrates its Ambition as a Pharmaceutical Developer

If it is about cures and treatment of Cancer, it is a certainty that Seattle Genetics “has truly stepped up to the plate.” Seattle, as a city, recently, welcomed a visit from Vice-President Joe Biden. Mr. Biden visited the city’s Cancer Research Community. The preceding action, on the part of Mr. Biden, is indicative of Seattle being a true Centralized location as it pertains to Research of Cancer. Playing a hand, in Seattle’s efforts, in finding cures for Cancer is Seattle Genetics.

Seattle Genetics, demonstrates its integrity, by way of developing pharmaceuticals, specific to various lymphomas. The fact it has pharmaceuticals, in process; and that the company is experiencing an impressive spurt of growth, certainly sets the region apart from that of other Cancer Research regions.

Seattle Genetics is attempting to broaden usage of its 1st pharmaceutical and to widen its drug line with that of new, safe, effective products. Further, it is hiring more people.

Once again: The preceding facts, demonstrate, the ambition tied to the company. The ambitious nature of the company comes by way of its pharmaceutical development within the Seattle area. The metropolitan area of Seattle, as stated, is well known for its efforts with regard to Cancer research; and pharmaceutical development.

The preceding said, the company, now, has underway, the Phase 3 trial, of its drug Adecetris. The pharmaceutical, as to its development, is made specifically for the treatment of Hodgkins lymphoma. The company, is trying out its only commercialized pharmaceutical, within the scope of various cancer-related circumstances. It has, summarily, been tested in more than 70 trials; against various lymphomas. The information was shared, with the public, by the company’s CEO Clay Siegell.

As indicated above, the pharmaceutical’s use is relative to fighting lymphomas. The drug sales were significant in 2015, resulting in an amount of $226 million in the United States and Canada. Sales, projected for 2016, will run in the ballpark range of $255 million to $275 million.

The company is, additionally, partnered with Takeda Pharmaceutical. The partner company sells the drug, outside of the United States.

The company has twelve pharmaceuticals under development. The company is wishing to place another drug into Phase 3 clinical trails called 33A. That particular pharmaceutical is used to treat Acute Myeloid Leukemia. Additionally, the company has a drug for Breast Cancer; and two drugs for Bladder Cancer.

The preceding said, the company, due to its explosive growth, is currently hiring, too. Seattle Genetics plans on hiring one-hundred employees, mainly within the operation’s area of its organization, as opposed to research. It is adding twenty new employees to its office in Switzerland. The company, too, has room for 350 more people. Historically, the company has added 100 people, annually, for the preceding five-years, according to the company’s CEO: Siegell.

Notes regarding Clay Siegell–CEO of Seattle Genetics:

The co-founder of Seattle Genetics is Clay B Siegall. Dr. Siegall co-established the company in 1998. He is President of the Company, and its CEO as well as its Chairman of the Board. Dr. Siegell, received training as a scientist, with the emphasis placed on certain Cancers and the treatments associated with those Cancers. Dr. Siegell believes in innovation—and as such, he has established the “root” of Seattle Genetics, as that of innovation, or a creative and scientific approach with regard to the treatment of Cancer. The company is rigorous, as to its research and its development of pharmaceuticals. The underlying reason, for the preceding passions of Dr. Siegell, is a commitment to those individuals, requiring a cure for Cancer. Dr. Siegell , has, successfully, led the company to its current impressive lead position, within the community, by means of development of antibody drug conjugates, referred to by the acronym of ADCs. He also secured FDA approval, in 2011, of the company’s first ADC product, known as ADCETRIS®. By partnering with Takeda Pharmaceutical Company, the drug, ADCETRIS®, is now known far and wide. It is currently an international brand that has been approved in over sixty nations.

Seattle Genetics, has entered into various strategic licenses for its ADC highly refined technology, with companies such as Genentech (Roche), among others. The result is: $325 million has been generated, up to the current time. The preceding approach and income generation has occurred under the leadership of Dr. Siegall. Additionally, more than twenty clinical developments, in way of internalized and collaborative programs, are making use of the company’s technology. Dr. Siegall is also a leader, pertinent to raising Capital. Doctor Siegell has successfully secured well over $1.2 billion by means of public financing and private financing—inclusive of the company’s public offering, in 2001. On the road to co-founding his own company, Dr. Siegell was with the Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Siegell’s tenure, there, lasted from 1991 to 1997. He was with the National Cancer Institute and National Institutes of Health from 1988 to 1991. Dr. Siegall received his Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland. Dr. Siegell is on the Board of Directors of many well-known companies and has received many outstanding achievement awards. His dedication to that of Cancer Research and finding cures, for the many types of Cancers, is well-appreciated within the Cancer Research Community.